check_circleStudy Completed

Postmenopause, Pharmacokinetics

Study to assess drospirenone's (DRSP) potential to inhibit Cytochrome P450 3A4 in healthy postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
25
Trial Dates
May 2003 - September 2003
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Drospirenone (DRSP, BAY86-5131)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Double-blind, randomized, crossover study to assess drospirenone's (DRSP) potential to inhibit Cytochrome P450 3A4 by evaluating the interaction between DRSP at steady state and single doses of the model substrate midazolam in healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A